PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2017 | 68 | 1 |
Tytuł artykułu

The role of macronutrient intake in reducing the risk of obesity and overweight among carriers of different polymorphisms of FTO gene. A review

Treść / Zawartość
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
Obesity is a growing problem worldwide. The risk of the excessive body weight occurrence is a multifactorial issue. Environmental factors, lifestyle habits, diet, physical activity level, as well as genetic predisposition can increase obesity risk. One of the genes studied – the FTO gene - plays a crucial role in obesity occurrence. Individuals who carry risk alleles of specific single nucleotide polymorphisms (SNP) have a greater risk of being overweight. Recent studies revealed that specific macronutrient diet composition can influence differently on the FTO expression. The aim of this article is to review the recent literature on the topic of the FTO gene, its influence on overweight and obesity prevalence and the role of diet in modifying its impact on the risk of the excessive body weight occurrence. There are not many studies focusing on the dietary intervention influence on the FTO gene expression. As far as it has been researched it seems that the proper dietary habits can modify the FTO gene risk allele influence on obesity susceptibility.
PL
Otyłość jest rosnącym problemem na całym świecie. Ryzyko występowania nadmiernej masy ciała stanowi problem wieloczynnikowy. Czynniki środowiskowe, styl życia, dieta, poziom aktywności fizycznej, a także predyspozycje genetyczne mogą zwiększać ryzyko otyłości. Jeden z badanych genów - gen FTO - odgrywa kluczową rolę w występowaniu otyłości. Osoby, które są nosicielami alleli ryzyka specyficznych polimorfizmów pojedynczych nukleotydów (ang. SNP - Single Nucleotide Polymorphism) tego genu charakteryzują się większym ryzykiem wystąpienia nadwagi. Najnowsze badania wykazały, że specyficzny udział makroskładników diety może wpływać w różny sposób na ekspresję FTO. Celem niniejszego artykułu jest przegląd najnowszej literatury na temat genu FTO, jego wpływ na częstość występowania nadwagi i otyłości oraz roli diety w modyfikacji jego wpływu na ryzyko wystąpienia nadmiernej masy ciała. Niewiele jest badań dotyczących wpływu interwencji dietetycznych na ekspresję genu FTO. Tak dalece jak to zostało zbadane wydaje się, że odpowiednie nawyki żywieniowe mogą modyfikować wpływ alleli genu FTO na ryzyko wystąpienia otyłości.
Wydawca
-
Rocznik
Tom
68
Numer
1
Opis fizyczny
p.5-13,ref.
Twórcy
  • Department of Dietetics, Wroclaw Medical University, 34 Parkowa, 51-616 Wroclaw, Poland
  • Department of Dietetics, Wroclaw Medical University, 34 Parkowa, 51-616 Wroclaw, Poland
Bibliografia
  • 1. Adamska E., Ostrowska L.: Nutrigenetyka i nutrigenomika a leczenie otyłości i chorób towarzyszących [Nutrigenetics and nutrigenomics and treatment of obesity and associated diseases]. Forum Zaburzeń Metabolicznych 2010; 1(3): 156-167 (in Polish).
  • 2. Ahmad T., Lee I., Pare G., Chasman D.I., Rose L. , Ridker P.M., Mora S.: Lifestyle interaction with fat mass and obesity-associated (FTO) genotype and risk of obesity in apparently healthy U.S.. Women. Diab Care 2011; 34,(3):675-680.
  • 3. Baik I., Shin C.: Interactions between the FTO rs9939609 polymorphism, body mass index, and lifestyle-related factors on metabolic syndrome risk. Nutr Res Pract 2012; 6: 78-85.
  • 4. Brunkwall L., Ericson U., Hellstrtand S., Gullberg B., Orho-Melander M., Sonestedt E.: Genetic variation in the fat mass and obesity-associated gene (FTO) in association with food preferences in healthy adults. Food Nutr Res 2013; 57: 0.3402/fnr.v57i0.20028.
  • 5. Cheung M.K., Gulati P., O’Rahilly S., Yeo G.S.: FTO expression is regulated by availability of essential amino acids. Int J Obes 2013; 37(5): 744-747.
  • 6. Cheung M.K.M., Yeo G.S.H. :FTO biology and obesity: why do a billion of us weight 3 kg more?. Front Endocrinol. 2011; 2(4): 10.3389/fendo.2011.00004.
  • 7. Claussnitzer M., Simon N., Dankel S.N., Kyoung-Han K., Quon G., Meuleman W., Haugen Ch., Glunk V., Sousa I..S, Beaudtu J.L., Puviindran V., Abdennur N.A., Liu J., Svenson P-A., Hsu Y-H., Drucker D.J., Mellgren G., Hui Ch-Ch., Hauner H., Kellis M.: FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med 2015: 373: 895-907.
  • 8. Corella D., Arnett D.K., Tucker K.L., Kabagambe E.K., Tsai M., Parnell L.D., Lai C.Q., Lee Y.C., Warodomwichit D., Hopkins P.N., Ordovas J.M.: A high intake of saturated fatty acids strenghens the association between the fat mass and obesity-associatied gene and BMI. J Nutr 2011; 141(12): 2219-2225.
  • 9. Corella D., Ortega-Azorin C., Sorli J.V., Covas I.M., Carasco P., Salas-Salvadó J., Martínez-González M.Á., Arós F., Lapetra J., Serra-Majem L., Lamuela-Raventos R., Gómez-Gracia E., Fiol M., Pintó X., Ros E., Martí A., Coltell O., Ordovás J.M., Estruch R.: Statistical and biological gene-lifestyle interactions of MC4R and FTO with diet and physical activity on obesity: new effects on alcohol consumption. PLoS ONE 2012; 7(12): e52344.
  • 10. De Luis D.A., Aller R., Izaola O., de laFuente B., Conde R., Sagrado M.G., Primo D.: Evaluation of weight loss and adipocytokines levels after two hypocaloric diets with different macronutrient distribution in obese subjects with rs9939609 gene variant. Diabetes Metab Res Rev 2012; 28(8): 663-668.
  • 11. De Luis D.A., Aller R., Izaola O., Pacheco D.: Role of rs9939609 FTO gene variant in weight loss, insulin resistance and metabolic parameters after a high monounsaturated vs high polyunsaturated fat hypocaloric diets. Nutr Hosp 2015; 32(1): 175-181.
  • 12. Descamps O.S., Tarantino E., Guilmot P.F.: Does FTO have a paradoxical effect in fetal life?. BMC Genetics 2014, 15, 145.
  • 13. Dina C., Meyre D., Gallina S., Durand E., Körner A., Jackobson P., Carlsson L.M., Kiess W., Vatin V., Lecoeur C., Delplanque J., Vaillant E., Pattou F., Ruiz J., Weill J., Levy-Marchal C., Horber F., Potoczna N., Hercberg S., Le Stunff C., Bougnères P., Kovacs P., Marre M., Balkau B., Cauchi S., Chèvre J.C., Froguel P.: Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 2007; 39(6): 706-707.
  • 14. Dlouhá D., Suchánek P., Lánská V., Hubáček J.A.: Body mass index change in females after short-time life style intervention is not dependent on the FTO polymorphism. Physiol Res 2011; 60(1): 199-202.
  • 15. Doo M., Yangha K.: Obesity: Interactions of Genome and Nutrient Intake. Prev Nutr Food Sci 2015; 20(1): 1-7.
  • 16. Frayling T.M., Timpson N.J., Weedon M.N., Zeggini E., Freathy R.M., Lindgren C.M. Perry J.R., Elliott K.S., Lango H., Rayner N.W., Shields B., Harries L.W., Barrett J.C., Ellard S., Groves C.J., Knight B., Patch A.M., Ness A.R., Ebrahim S., Lawlor D.A., Ring S.M., Ben-Shlomo Y., Jarvelin M.R., Sovio U., Bennett A.J., Melzer D., Ferrucci L., Loos R.J., Barroso I., Wareham N.J., Karpe F., Owen K.R., Cardon L.R., Walker M., Hitman G.A., Palmer C.N., Doney A.S., Morris A.D., Smith G.D., Hattersley A.T., McCarthy M.I.: A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316(5826): 889-894.
  • 17. Gawęcki J.: Żywienie człowieka. Podstawy nauki o żywieniu [Human nutrition. Basics of food science]. Warszawa, Wydawnictwo Naukowe PWN, 2012 (in Polish).
  • 18. Goni L., Cuervo M., Milagro F.I., Martinez J.A.: A genetic risk tool for obesity predisposition assessment and personalized nutrition imprementation based on macronutrient intake. Genes Nutr 2015: 10(1): 445.
  • 19. Grau K., Hansen T., Holst C., Astrup A., Saris W.H., Arner P., Rössner S., Macdonald I., Polak J., Oppert J.M., Langin D., Martinez J.A., Pedersen O., Sørensen T.I.: Macronutrient-specyfic effect of FTO rs9939609 in response to a 10-week randomized hypo-energetic diet among obese Europeans. Int J Obes 2009; 33(11): 1227-1234.
  • 20. Gulati P., Yeo G.S.H.: The biology of FTO: from nucleic acid demethylase to amino acid sensor. Diabetologia 2013; 56(10): 2113-2121.
  • 21. Hanaken M., Raitakari O.T., Lehtimäki T., Pletonen N., Pahkala K., Sillanmäki L.: FTO genotype is associated with body mass indoex after the age of seven years but not with Energy intake or leisure-time physical actibity. J Clin Endocrinol Metab 2009; 94(4): 1281-1287.
  • 22. Haupt A., Thamer C., Machann J., Kirchoff K., Stefan N., Tschritter O., Machicao F., Schick F., Häring H.U., Fritsche A.: Impact of variation of FTO gene on whole body fat distribution, ectopic fat, weight loss. Obesity 2008; 16(8): 1969-1972.
  • 23. Henning B.J., Fulford A.J., Sirugo G., Rayco-Solon P., Hattersley A.T., Frayling T.M., Prentice A.M.: FTO gene variation and measures of body mass in an African population. BMC Med Genet 2009; 10: 21.
  • 24. Jackobsson J.A., Almén M.S., Benedict C., Hedberg L.A., Michaëlsson K., Brooks S., Kullberg J., Axelsson T., Johansson L., Ahlström H., Fredriksson R., Lind L., Schiöth H.B.: Detailed analysis of variants in FTO in association with body composition in a cohort of 70-year-olds suggests a weakend effect among elderly. PloS One 2011; 6(5): e20158.
  • 25. Johnson L., van Jaarsveld C.H.M., Emmett P.M., Rogers I.S., Ness A.R., Hattersley A.T., Timpson N.J., Smith G.D., Jebb S.A.: Dietary Energy Density Affects Fat Mass in Early adolescence and is not modified by FTO variants. PloS ONE 2009; 4(3): e4594.
  • 26. Kilpeläinen T.O., Qi L., Barage S., Sharp S.J., Sonestedt E., Demerath E., Ahmad T., Mora S., Kaakinen M..,Sandholt C.H., Holzapfel C., Autenrieth C.S., Hyppönen E., Cauchi S., He M., Kutalik Z., Kumari M., Stančáková A., Meidtner K., Balkau B., Tan J.T., Mangino M., Timpson N.J., Song Y., Zillikens M.C., Jablonski K.A., Garcia M.E., Johansson S., Bragg-Gresham J.L., Wu Y., van Vliet-Ostaptchouk J.V., Onland-Moret N.C., Zimmermann E., Rivera N.V., Tanaka T., Stringham H.M., Silbernagel G., Kanoni S., Feitosa M.F., Snitker S., Ruiz J.R., Metter J., Larrad M.T., Atalay M., Hakanen M., Amin N., Cavalcanti-Proença C., Grøntved A., Hallmans G., Jansson J.O., Kuusisto J., Kähönen M., Lutsey P.L., Nolan J.J., Palla L., Pedersen O., Pérusse L., Renström F., Scott R.A., Shungin D., Sovio U., Tammelin T.H., Rönnemaa T., Lakka T.A., Uusitupa M., Rios M.S., Ferrucci L., Bouchard C., Meirhaeghe A., Fu M., Walker M., Borecki I.B., Dedoussis G.V., Fritsche A., Ohlsson C., Boehnke M., Bandinelli S. et al.: Physical activity attenuates the influence of FTO variants on obesity risk, a meta-analysis of 218, 166 adults and 19,268 children. PLoS Medicine 2011; 8: e1001116.
  • 27. King R.C., Stansfield W.D.: Słownik terminów genetycznych [The glossary of genetics]. Poznań, Osrodek Wydawnictw Naukowych, 2002 (in Polish).
  • 28. Kolackov K., Łaczmiański Ł., Bednarek-Tupikowska G.: Wpływ polimorfizmów genu FTO na ryzyko otyłości [The influence of FTO gene polymorphisms on the obesity suscebility]. Endokrynol Otyłość 2010; 6(2): 101-107 (in Polish).
  • 29. Koziołkiewicz M.: Koncepcje nutrigenomiki [The concepts of nutrigenomics]. Biotechnologia 2009; 4(87): 9-34 (in Polish).
  • 30. Li H., Kilpelainen T.O., Liu C., Zhu J., Hu C., Yang Z., Zhang W., Bao W., Cha S., Wu Y., Yang T., Sekine A., Choi B.Y., Yajnik C.S., Zhou D., Takeuchi F., Yamamoto K., Chan J.C., Mani K.R., Been L.F, Imamura M., Nakashima E., Lee N., Fujisawa T., Karasawa S., Wen W., Joglekar C.V., Lu W., Chang Y., Xiang Y., Gao Y., Liu S., Song Y., Kwak S.H., Shin H.D., Park K.S., Fall C.H., Kim J.Y., Sham P.C., Lam K.S., Zheng W., Shu X., Deng H., Ikegami H., Krishnaveni G.V., Sanghera D.K., Chuang L., Liu L., Hu R., Kim Y., Daimon M., Hotta K., Jia W., Kooner J.S., Chambers J.C., Chandak G.R., Ma R.C., Maeda S., Dorajoo R., Yokota M., Takayanagi R., Kato N., Lin X., Loos R.J.: Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia 2012; 55(4): 981-995
  • 31. Liu G., Zhu H., Lagou V., Gutin B., Stallmann- Jorgensen I.S., Treiber F.A, Donag Y., Sneider H.: FTO variant rs9939609 is associated with body mass index and waist circumference, but not with energy intake or physical activity in European- and Afro- American youth. BMC Med Genet 2010; 11: 57.
  • 32. Livingstone K.M., Celis-Morales C., Lara J., Ashor A.W., Lovefrove J.A., Martinez J.A., Saris W.H., Gibney M., Manios Y., Traczyk I., Drevon C.A., Daniel H., Gibney E.R., Brennan L., Bouwman J., Grimaldi K.A., Mathers J.C.: Association between FTO genotype and total energy and macronutrient intake in adults: a systematic review and meta-analysis. Obes rev 2015; 16(8): 666-678.
  • 33. Łuszczyński W., Zalewski G., Bossowski A.: The association of the FTO rs9939609 polymorphism with obesity and metabolic risk factors for cardiovascular diseases in Polish children. J Physiol Pharmacol 2012; 63(3): 241-248.
  • 34. Matsuo T., Nakata Y., Murokate Y., Hotta K., Tanaka K.: Effects of FTO genotype on weight loss and metabolic risk factors in response to calorie restriction among Japanese women. Obesity 2012; 20: 1122-1126.
  • 35. Moleres A., Rendo-Urteaga T., Zulet A.M., Macros A., Campoy C., Garagorri J.M., Martínez J.A., Azcona-Sanjulián M.C., Marti A., EVASYON Study Group: Obesity Susceptibility Loci on Body Mass Index and weight loss in spanish adolescents after a lifestyle intervention. J Pediatr 2012; 161(3): 466-470.
  • 36. Muller T.D., Hinney A., Scherag A., Nguyen T.T., Schreiner F., Schäfer H.: Fat mass and obesity associated’ gene (FTO), no significant association of variant rs9939609 with weight loss in a lifestyle intervention and lipid metabolism markers in German obese children and adolescents. BMC Med Genet 2008; 9: 85.
  • 37. Obesity and overweight. WHO report. Available http://www.who.int/mediacentre/factsheets/fs311/en/ (Accessed: 2015.10.30).
  • 38. Olszewski P.K., Frediksson R., Olszewska A.M., Stephansson O., Alsiö J., Radomska J.K., Levine A.S., Schiöth H.B.: Hypothalamic FTO is associated with the regulatin of energy intake not feeding reward. BMC Neurosci 2009; 10: 129.
  • 39. Park S.L., Cheng I., Pendergrass S.A., Kucharska-Newton A.M., Lim U., Ambite J.L. Caberto C.P., Monroe K.R., Schumacher F., Hindorff L.A., Oetjens M.T., Wilson S., Goodloe R.J., Love S.A., Henderson B.E., Kolonel L.N., Haiman C.A., Crawford D.C., North K.E, Heiss G., Ritchie M.D., Wilkens L.R., Le Marchand L.: Association of the FTO obesity risk variant rs8050136 with percentage of energy intake from fat in multiple racial/ethnic population. Am J Epidemiol 2013; 178(5): 780-790.
  • 40. Peng S., Zhu Y., Xu F., Ren X., Li X., Lai M.: FTO gene polymorphisms and obesity risk: a meta-analysis. Medicine 2011; 9(71): 10.1186/1741-7015-9-71.
  • 41. Prospective Studies Collaboration. Body-mass index andcause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373(9669): 1083–1096.
  • 42. Pyrzak B., Wisniewska A., Majcher A., Tysarowski A., Demkow U.: Relation of fat-mass and obesity-associated gene polymorphism to fat mass content and body mass index in obese children. Adv Exp Med Biol 2013; 756: 255-262.
  • 43. Qi Q., Kilpeläinen T.O., Downer M.K., Tanaka T., Smith C.E., Sluijs I., Sonestedt E., Chu A.Y., Renström F., Lin X., Ängquist L.H., Huang J., Liu Z., Li Y., Asif Ali M., Xu M., Ahluwalia T.S., Boer J.M., Chen P., Daimon M., Eriksson J., Perola M., Friedlander Y., Gao Y.T., Heppe D.H., Holloway J.W., Houston D.K., Kanoni S., Kim Y.M., Laaksonen M.A., Jääskeläinen T., Lee N.R., Lehtimäki T., Lemaitre R.N., Lu W., Luben R.N., Manichaikul A., Männistö S., Marques-Vidal P., Monda K.L., Ngwa J.S., Perusse L., van Rooij F.J., Xiang Y.B., Wen W., Wojczynski M.K., Zhu J., Borecki I.B., Bouchard C., Cai Q., Cooper C., Dedoussis G.V., Deloukas P., Ferrucci L., Forouhi N.G., Hansen T., Christiansen L., Hofman A., Johansson I., Jørgensen T., Karasawa S., Khaw K.T., Kim M.K., Kristiansson K., Li H., Lin X. et al.: FTO gene variants, dietary intake and body mass index:177 330 individuals. Hum Molec Genet 2014; 23(25): 6961-6972.
  • 44. Razquin C., Martinez J.A., Martinez-Gonzales M.A., Bes-Rastrollo M., Fernández-Creuhuet J., Marti A.: A 3-year intervention with a Mediterranean diet modified the association between the rs9939609 gene variant in FTO and body weight changes. Int J Obes 2010; 34(2): 266-272.
  • 45. Reinehr T., Hinney A., Toschke A.M., Hebebrand J.: Aggravating effect of INSIGT2 and FTO on overweight reduction in a one-year lifestyle intervention. Arch Dis Child 2009; 94(12): 965-967.
  • 46. Sales N.M.R., Pelegrini P.B., Goersch M.C.: Nutrigenomics: Definitions and Advances of This New Science. J Nutr Metab 2014; 202759.
  • 47. Scuteri A., Sanna S., Chen W-M., Uda M., Albai G., Strait J., Najjar S., Nagaraja R., Orrú M., Usala G., Dei M., Lai S., Maschio A., Busonero F., Mulas A., Ehret G.B., Fink A.A., Weder A.B., Cooper R.S., Galan P., Chakravarti A., Schlessinger D., Cao A., Lakatta E., Abecasis G.R.: Genome-wide Association Scan show genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 2007; 3, 10.1371/journal.pgen.0030115.
  • 48. Single Nutrient Polymorphism Data Base. Available http://www.snpedia.com/index.php/Rs1421085 (Accessed: 2015.12.10).
  • 49. Sobczyk-Kopciol A., Broda G., Wojnar M., Kurjata P., Jakubczyk A., Klimkiewicz A., Ploski R.: Inverse association of the obesity predisposing FTO rs9939609 genotype with alcohol consumption and risk for alcohol dependence. Addiction 2011; 105(4): 739-748.
  • 50. Sonestedt E., Roos Ch., Gullberg B., Ericson U., Wirfält E., Orho-Melander M.: Fat and carbohydrate intake modify the association between genetic variation in the FTO genotype and obesity. Am J Clin Nutr 2009; 90: 1418-1425.
  • 51. Tanofsky-Kraff M., Han J.C., Anadalingam K., Shomaker L.B., Columbo K.M., Wolkoff L.E., Kozlosky M., Elliott C., Ranzenhofer L.M., Roza C.A., Yanovski S.Z., Yanovski J.A.: The FTO gene rs9939609 obesityrisk allele and loss of control over eating. Am J Clin Nutr 2009; 90(6): 1483-1488.
  • 52. Tercjak-Rećko M., Łuszczyński W., Bernatowicz P., Zalewski G., Rembińska M., Lachowska U., Rećko P., Suchoń P., Czaban M., Sokal J., Kopalińska A., Pajer Z., Bogdanowicz K., Nikliński J., Bossowski A.: Polymorphism rs9939609 of FTO gene is related to the Body Mass Index in children from podlaskie province. Med Wieku Rozwoj 2012; 16(1): 53-61.
  • 53. Tung L.Y., Ayuso .E, Shan X., Bosch F., O’Rahilly S., Coll A.P., Yeo G.S.H.: Hypothalamic-specyfic manipulation of FTO, the ortholog of human obesity gene FTO, affects food intake in rats. PloS ONE 2010; 5(1): 0.1371/journal.pone.0008771.
  • 54. Wåhlén K., Sjölin E., Hoffstedt J.: The common rs9939609 gene variant of the fat mass and obesityassociated gene FTO is related to fat cell lipolysis. J Lipid Res 2008; 49: 607-611.
  • 55. Wang X., Lu Z., Gomez A., Hon G.C., Yue Y., Han D., Fu Y., Parisien M., Dai Q., Jia G., Ren B., Pan T., He Ch.: M6a-dependent regulation of messenger stability. Nature 2014; 505(7491), 117-120.
  • 56. Wardle J., Carnell S., Haworth C.M., Faroogi I.S., O’Rahilly S., Plomin R.: Obesity associated genetic variation in FTO is associated with diminished satiety. J Clin Endocrinol Metab 2008; 93(9): 3640-3643.
  • 57. World Health Organization: The challenge of obesity in the WHO European Region. Fact sheet EURO 2005; 13: 1-4.
  • 58. Yeo G.S.H.: The role of the FTO (Fat mass and obesity related) locus in regulating body size and composition. Molec Cell Endocrinol 2014; 397(1-2): 34-41.
  • 59. Zhang X., Qi Q., Zhang C., Hu F.B., Sacks F.M., Qi L.: FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets. Diabetes 2012; 61(11): 3005-3011.
  • 60. Zlatohavek L., Varblik M., Motykova E., Ceska R., Vasickova L., Dlouha D., Hubacek J.A.: FTO and MC4R gene variant determine BMI changes in children after intensive lifestyle intervention. Clin Biochem 2013; 46(4-5): 313-316.
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.agro-829c8d39-2965-4c22-9f1f-53a0a11c7394
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.